These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 25713356)

  • 1. Whole-genome RNAi screen highlights components of the endoplasmic reticulum/Golgi as a source of resistance to immunotoxin-mediated cytotoxicity.
    Pasetto M; Antignani A; Ormanoglu P; Buehler E; Guha R; Pastan I; Martin SE; FitzGerald DJ
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):E1135-42. PubMed ID: 25713356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The insulin receptor negatively regulates the action of Pseudomonas toxin-based immunotoxins and native Pseudomonas toxin.
    Liu XF; FitzGerald DJ; Pastan I
    Cancer Res; 2013 Apr; 73(7):2281-8. PubMed ID: 23348423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antitumor effects of immunotoxins are enhanced by lowering HCK or treatment with SRC kinase inhibitors.
    Liu XF; Xiang L; FitzGerald DJ; Pastan I
    Mol Cancer Ther; 2014 Jan; 13(1):82-9. PubMed ID: 24145282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced cytotoxicity of a
    Masilamani AP; Huber N; Nagl C; Dettmer-Monaco V; Monaco G; Wolf I; Schultze-Seemann S; Taromi S; Gratzke C; Fuchs H; Wolf P
    Front Pharmacol; 2023; 14():1211824. PubMed ID: 37484018
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Birinapant selectively enhances immunotoxin-mediated killing of cancer cells conditional on the IAP protein levels within target cells.
    Antignani A; Bilotta MT; Roth JS; Urban DJ; Shen M; Hall MD; FitzGerald D
    FASEB J; 2023 Dec; 37(12):e23292. PubMed ID: 37971407
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination treatments with the PKC inhibitor, enzastaurin, enhance the cytotoxicity of the anti-mesothelin immunotoxin, SS1P.
    Mattoo AR; Pastan I; Fitzgerald D
    PLoS One; 2013; 8(10):e75576. PubMed ID: 24130723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Releasable PEGylation of mesothelin targeted immunotoxin SS1P achieves single dosage complete regression of a human carcinoma in mice.
    Filpula D; Yang K; Basu A; Hassan R; Xiang L; Zhang Z; Wang M; Wang QC; Ho M; Beers R; Zhao H; Peng P; Zhou J; Li X; Petti G; Janjua A; Liu J; Wu D; Yu D; Zhang Z; Longley C; FitzGerald D; Kreitman RJ; Pastan I
    Bioconjug Chem; 2007; 18(3):773-84. PubMed ID: 17346030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotoxin and Taxol synergy results from a decrease in shed mesothelin levels in the extracellular space of tumors.
    Zhang Y; Xiang L; Hassan R; Pastan I
    Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17099-104. PubMed ID: 17940013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor-directed radiation and the immunotoxin SS1P in the treatment of mesothelin-expressing tumor xenografts.
    Hassan R; Williams-Gould J; Steinberg SM; Liewehr DJ; Yokokawa J; Tsang KY; Surawski RJ; Scott T; Camphausen K
    Clin Cancer Res; 2006 Aug; 12(16):4983-8. PubMed ID: 16914588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autophagy-Interfering Nanoboat Drifting along CD44-Golgi-ER Flow as RNAi Therapeutics for Hepatic Fibrosis.
    Wang Y; Xiong L; Dong Z; Ran K; Bai W; Mo Z; Huang K; Ye Y; Tao Y; Yin S; Li M; He Q
    ACS Appl Mater Interfaces; 2023 Jun; 15(24):28941-28953. PubMed ID: 37290012
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The development and characterization of a human mesothelioma in vitro 3D model to investigate immunotoxin therapy.
    Xiang X; Phung Y; Feng M; Nagashima K; Zhang J; Broaddus VC; Hassan R; Fitzgerald D; Ho M
    PLoS One; 2011 Jan; 6(1):e14640. PubMed ID: 21305058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional genomics reveals genes involved in protein secretion and Golgi organization.
    Bard F; Casano L; Mallabiabarrena A; Wallace E; Saito K; Kitayama H; Guizzunti G; Hu Y; Wendler F; Dasgupta R; Perrimon N; Malhotra V
    Nature; 2006 Feb; 439(7076):604-7. PubMed ID: 16452979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancing immunotoxin cell-killing activity via combination therapy with ABT-737.
    Fitzgerald DJ; Moskatel E; Ben-Josef G; Traini R; Tendler T; Sharma A; Antignani A; Mussai F; Wayne A; Kreitman RJ; Pastan I
    Leuk Lymphoma; 2011 Jun; 52 Suppl 2(Suppl 2):79-81. PubMed ID: 21599608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Signal-mediated sorting of membrane proteins between the endoplasmic reticulum and the golgi apparatus.
    Teasdale RD; Jackson MR
    Annu Rev Cell Dev Biol; 1996; 12():27-54. PubMed ID: 8970721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport.
    Moffat K; Howell G; Knox C; Belsham GJ; Monaghan P; Ryan MD; Wileman T
    J Virol; 2005 Apr; 79(7):4382-95. PubMed ID: 15767438
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Golgi apparatus: lessons from Drosophila.
    Kondylis V; Rabouille C
    FEBS Lett; 2009 Dec; 583(23):3827-38. PubMed ID: 19800333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sec22 and Memb11 are v-SNAREs of the anterograde endoplasmic reticulum-Golgi pathway in tobacco leaf epidermal cells.
    Chatre L; Brandizzi F; Hocquellet A; Hawes C; Moreau P
    Plant Physiol; 2005 Nov; 139(3):1244-54. PubMed ID: 16244155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HA22 (R490A) is a recombinant immunotoxin with increased antitumor activity without an increase in animal toxicity.
    Bang S; Nagata S; Onda M; Kreitman RJ; Pastan I
    Clin Cancer Res; 2005 Feb; 11(4):1545-50. PubMed ID: 15746059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Passage through the Golgi is necessary for Shiga toxin B subunit to reach the endoplasmic reticulum.
    McKenzie J; Johannes L; Taguchi T; Sheff D
    FEBS J; 2009 Mar; 276(6):1581-95. PubMed ID: 19220458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids.
    Wenning LA; Murphy RM
    Biotechnol Bioeng; 1999 Mar; 62(5):562-75. PubMed ID: 10099565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.